These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 24899638)
1. Mycophenolate mofetil in the treatment of lupus vasculopathy. Rathi M; Nada R Lupus; 2014 Oct; 23(11):1217-8. PubMed ID: 24899638 [No Abstract] [Full Text] [Related]
7. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil. Cetkovská P; Pizinger K Int J Dermatol; 2006 Mar; 45(3):320-2. PubMed ID: 16533240 [TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil: a magic bullet for lupus? McCune WJ; Riskalla MM J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751 [No Abstract] [Full Text] [Related]
9. [Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations]. Daugas E Rev Med Interne; 2008 Sep; 29(9):710-7. PubMed ID: 18565625 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection. Caponnetto C; Rossi E; Primavera A Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187 [No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus. Mak A; Mok CC Lupus; 2005; 14(10):856-8. PubMed ID: 16302683 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Alba P; Karim MY; Hunt BJ Lupus; 2003; 12(8):633-5. PubMed ID: 12945724 [TBL] [Abstract][Full Text] [Related]
13. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil. Svobodova B; Hruskova Z; Rysava R; Tesar V Lupus; 2011 Nov; 20(13):1452-4. PubMed ID: 21868432 [No Abstract] [Full Text] [Related]
14. [Therapeutic possibilities in lupus nephropathies. Abundance of means and difficulties of choice]. Suc JM; Conte J; Mignon-Conte M Nouv Presse Med; 1975 Jan; 04(2):85-6,88,90. PubMed ID: 1138228 [No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report. Al Rashidi A; Alajmi M; Hegazi MO Lupus; 2011 Dec; 20(14):1551-3. PubMed ID: 21828160 [TBL] [Abstract][Full Text] [Related]
16. [Anuria in the course of acute lupus]. Ponticelli C; Rivolta E; Limido D; Tarantino A; Ibmasciati E Minerva Nefrol; 1974; 21(3):191-6. PubMed ID: 4463299 [No Abstract] [Full Text] [Related]
17. Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus. Subedi A; Magder LS; Petri M Rheumatol Int; 2015 Oct; 35(10):1687-92. PubMed ID: 25836768 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil. Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472 [TBL] [Abstract][Full Text] [Related]
19. Diverse vascular lesions in systemic lupus erythematosus and clinical implications. Tan Y; Yu F; Liu G Curr Opin Nephrol Hypertens; 2014 May; 23(3):218-23. PubMed ID: 24670401 [TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus in the younger patient: survival studies. Abeles M; Urman JD; Weinstein A; Lowenstein M; Rothfield NF J Rheumatol; 1980; 7(4):515-22. PubMed ID: 7420333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]